![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SOLARA.png)
Share the post "Solara Active Pharma Sciences ‘s Q3 2024-25 Latest News: Profit Grows by 102.94% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 20.74 % in the past year, decrease in net sales/revenue by -13.44 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 102.39 %. Marginal increase in other income during this quarter, up by 365.63%. 🔹 Profit over the Year and quarter: Challenges in sustaining profitability for Solara Active Pharma Sciences Limited. Profit dropped by -102.94 % Year to Year, Solara Active Pharma Sciences Limited’s profitability increased by 1 % in this quarter. 🔹 EPS over the Year and quarter: EPS declined by -102.65 % Year to Year. EPS decreased by -20.08 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 248.73 Cr | Rs. 346.95 Cr | Rs. 300.31 Cr | -13.44 % | + 20.74 % |
| Expenses | Rs. 410.42 Cr | Rs. 285.64 Cr | Rs. 242.63 Cr | -15.06 % | -40.88 % |
| Operating Profit | Rs. -161.69 Cr | Rs. 61.31 Cr | Rs. 57.68 Cr | -5.92 % | + 135.67 % |
| OPM % | -65.01 % | 17.67 % | 19.21 % | + 1.54 % | + 84.22 % |
| Other Income | Rs. -62.32 Cr | Rs. 0.32 Cr | Rs. 1.49 Cr | + 365.63 % | + 102.39 % |
| Interest | Rs. 25.37 Cr | Rs. 28.28 Cr | Rs. 26.54 Cr | -6.15 % | + 4.61 % |
| Depreciation | Rs. 25.96 Cr | Rs. 25.34 Cr | Rs. 24.54 Cr | -3.16 % | -5.47 % |
| Profit before tax | Rs. -275.34 Cr | Rs. 8.01 Cr | Rs. 8.09 Cr | + 1 % | + 102.94 % |
| Tax % | -0 % | 0 % | 0 % | 0 % | 0 % |
| Net Profit | Rs. -275.34 Cr | Rs. 8.01 Cr | Rs. 8.09 Cr | + 1 % | + 102.94 % |
| EPS in Rs | Rs. -76.49 | Rs. 2.54 | Rs. 2.03 | -20.08 % | + 102.65 % |
Today, we’re looking at Solara Active Pharma Sciences Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 20.74 %. However, it did see a marginal slip of -13.44 % from the previous quarter. Expenses decreased slightly by -15.06 % quarter-on-quarter, aligning with the annual decline of -40.88 %. Operating profit, while up 135.67 % compared to last year, faced a quarter-on-quarter dip of -5.92 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 84.22 %, but an expansion of 1.54 % sequentially. Other income rose by 365.63 % compared to the last quarter, despite an annual growth of 102.39 %. Interest expenses dropped significantly by -6.15 % from the previous quarter, yet the year-over-year increase remains at a moderate 4.61 %. Depreciation costs fell by -3.16 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -5.47 %. Profit before tax grew annually by 102.94 % but saw an increase from the preceding quarter by 1 %.
Net profit rose by 102.94 % year-on-year but experienced a 1 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 102.65 % but a quarterly fall of -20.08 %. In summary, Solara Active Pharma Sciences Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 248.73 Cr | Rs. 346.95 Cr | Rs. 300.31 Cr | -13.44 % | + 20.74 % |
| Expenses | Rs. 410.42 Cr | Rs. 285.64 Cr | Rs. 242.63 Cr | -15.06 % | -40.88 % |
| Operating Profit | Rs. -161.69 Cr | Rs. 61.31 Cr | Rs. 57.68 Cr | -5.92 % | + 135.67 % |
| Net Profit | Rs. -275.34 Cr | Rs. 8.01 Cr | Rs. 8.09 Cr | + 1 % | + 102.94 % |
| EPS in Rs | Rs. -76.49 | Rs. 2.54 | Rs. 2.03 | -20.08 % | + 102.65 % |
In reviewing Solara Active Pharma Sciences Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 20.74 % year-on-year growth, although there was a slight dip of -13.44 % from the previous quarter. Expenses decreased by -40.88 % compared to the previous year, with a decrease of -15.06 % quarter-on-quarter. Operating Profit surged by 135.67 % annually, and saw a -5.92 % decrease from the last quarter.
Net Profit showed yearly increase of 102.94 %, and experienced a 1 % increase from the previous quarter. Earnings Per Share (EPS) rose by 102.65 % annually, however dipped by -20.08 % compared to the last quarter. In essence, while Solara Active Pharma Sciences Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/FAMILYCARE.png)
